Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00026702 · ClinicalTrials.gov registry record

Search for New Methods to Detect Acute Renal Failure

A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Terminated
Registry status
226
Enrollment target

NCT00026702 is a clinical trial that was terminated before completion, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 226 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00026702 was terminated before completion, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

TERMINATED
Registry status
226 participants
Enrollment target

Study Summary

The purpose of this study is to find substances in the blood and urine that indicate that a person has kidney damage. It will identify proteins found only in patients with acute kidney failure but not in normal healthy people or in patients with volume depletion. Adults and children who are at least 3 years old who fall into one of the following four categories may be eligible for this study: 1. Are healthy and have normal kidney function 2. Have volume depletion (this condition differs from acute kidney failure in that it is easily treated with fluids) 3. Are at high risk of kidney failure 4. Have acute kidney failure (kidney shutdown) All study participants will have a history and physical examination. Up to four blood samples of 3 tablespoons each will be taken for laboratory analysis. Urine will be collected for analysis and to measure urine output. The participants length of stay in the study varies. People with normal kidney function will be in the study for 1 day and patients with volume depletion will be studied 3 days. The length of hospitalization of patients at high risk of kidney failure or in acute kidney failure will depend on the patient s condition and medication requirements. The results of this study may lead to the development of earlier and more accurate methods for diagnosing acute kidney failure. With earlier detection, treatment could be started earlier, possibly preventing further damage and helping recovery of injury that has already occurred.

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2000-06-07
Est. Completion 2026-03-12

What the Registry Record Tells You About NCT00026702

The ClinicalTrials.gov registry entry for NCT00026702 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 226 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00026702 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00026702 about?

NCT00026702 is a clinical study titled "Search for New Methods to Detect Acute Renal Failure". The purpose of this study is to find substances in the blood and urine that indicate that a person has kidney damage. It will identify proteins found only in patients with acute kidney failure but not in normal healthy people or in patients with volume depletion. Adults and children who are at leas...

What is the current status of trial NCT00026702?

This trial is currently terminated. The enrollment target is 226 participants. The study started on 2000-06-07. Estimated completion is 2026-03-12.

Who is sponsoring clinical trial NCT00026702?

This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.